SURVELLIANCE OF ANTI-ALLERGIC DRUGS FROM INDORE LOCALITY OF MADHYA PRADESH

Allergy is a disorder of the immune system often also referred to as atopy. Allergic reactions occur to environmental substances known as allergens; these reactions are acquired, predictable and rapid.The present paper through the light on the marketing survey of Antiallergic drugs and a comparison of drugs, having less drug-drug interaction and adverse drug reaction which benefits the patient's compliance towards the use allergy.  Market research of Antiallergic drugs was carried from Jan 2008 to May 2008; data's were collected from five doctor's cabin and ten chemist of Indore city.

Whole 8 pages article is available for download at Downloads section of Faramavita.Net

Accurate and complete expiry information now available with GenericsWeb Pipeline Scope

Finally, the generics industry has fast access to reliable key patent, SPC and data protection expiry information. Pipeline Scope, the latest release from industry experts GenericsWeb provides accurate and complete data for over 1400 INNs, across 37 countries, delivered through an interface that is easy to use and interpret.

Accurate and complete expiry information now available with GenericsWeb Pipeline Scope

Finally, the generics industry has fast access to reliable key patent, SPC and data protection expiry information. Pipeline Scope, the latest release from industry experts GenericsWeb provides accurate and complete data for over 1400 INNs, across 37 countries, delivered through an interface that is easy to use and interpret.

GenericsWeb Opens US Doors

1^st JULY 2008, Morristown, New Jersey. GenericsWeb, provider of premium Patent Intelligence Services to the Generic Pharmaceutical Industry, today opened the doors of its first US offices, strategically located in Morristown, New Jersey, the heart of the US pharmaceutical industry.

Taste masking method for bitter drug and taste less dispersible tablet: an overview

Rajendra Jangde, Shailendra Saraf, Sanjay Daharwal*, Swarnlata Saraf

Institute of pharmacy,

Pt. Ravishankar Shukla University, Raipur(C.G.), India 492010

Corresponding author*

Geneva, Switzerland; Westerbork, The Netherlands, April 21, 2008

RidePharm and 4Vision today announced their alliance for the further development of their customer and product portfolio

The companies will work together to increase their opportunities across Europe and beyond. In this alliance they will combine their capacities and present and future assignments.
Particular emphasis will be given to the all aspects in the field of business development and advisory functions for Biotech and Pharma companies.

'Conservative' pharmaceutical industry slow to take advantage of online marketing opportunities

While the internet has altered the landscape in the retail sector and revolutionized the airline industry, pharmaceutical companies have been slow to take advantage of the marketing opportunities offered by the medium. With existing sales and marketing strategies widely considered unsustainable, the industry needs to evolve and engage with its customers online, or it risks being left behind. 

Public-Private Partnerships between EC and EFPIA

Under FP7, Joint Technology Initiatives (JTIs) have been introduced to realise Public-Private Partnerships in research at European level and IMI is one of the first JTIs. The EC and the European Federation of Pharmaceutical Industries and Associations (EFPIA) joined forces to set up IMI after the former has identified biomedical research as a strategy priority to enhance the competitiveness of the EU.

Are Nanotubes related to Mesothelioma?

Nanotechnology is the emerging scientific field which includes the study of small, thin, carbon-based materials known as nanotubes (also called CNTs),  which are becoming widely used in a plethora of products ranging from technologically advanced items utilized by NASA to everyday items used in the home.  These nanotubes are increasingly popular due to their light weight and supreme strength, which is said to be stronger than steel.

MICROBIAL LIMIT TEST IN PHARMACEUTICAL PRODUCTS: AN OVERVIEW

The microbial limit tests are designed to perform the qualitative and quantitative estimations of specific viable microorganisms present in pharmaceutical substances or in the samples. Since, the pharmaceutical products deals with the formulation of various dosage form which ultimately be used by the human for alleviating certain kind of ailments to treat the dreadful diseases. Therefore, the test should be performed in all the dosage form to ensure that the formulation is free from any micro-organism and it also ensure that it will not going to harm the human body as concern to the micro-organism.

Drug Repositioning Strategies - Serendipity by design

Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly harsh market environment. As competition to inlicense candidates drives the price of this strategy up, repositioning presents a cost effective alternative.

Osteoarthritis - The COX-2 pipeline collapses

With several recent non-approvable decisions in the osteoarthritis market since 2006, Datamonitor has updated its forecast to account for the effect on the market. We have revised the market outlook over the next 10 years using the latest IMS data. We expect the market to grow steadily, with a CAGR from 2007 to 2017 of 3.2%, to reach sales of nearly $5.5 billion in 2017.

Acute Stroke: Commercial risk offsets high unmet need

Stroke is one of the top three causes of death and its incidence in the seven major markets is expected to increase in the next ten years because of an aging population. Long term disability caused by stroke is a major economic burden on healthcare systems, current treatment options are limited and general awareness of stroke is poor.

Online Patient Recruitment Strategies - Optimizing the clinical trial process

With the rising costs, length and complexity of clinical trials, drug development is subject to huge delays, translating into delays in getting a drug to market and millions of dollars in lost sales. Optimizing the recruitment process through web-based technologies can cut delays in clinical trials and can also be used to maintain relationships with patients to improve the clinical trial process.

Non-insulin antidiabetics – Incretin mimetics – leaders in a diverse pipeline

Datamonitor expects incretin mimetics to emerge as a major new therapeutic class in non-insulin antidiabetics, driven by an explosion in the patient population, safety fears surrounding established therapies and significant unmet patient needs.

Pricing & Reimbursement - Seven Major Markets Update

Governments and payers across the seven major markets are implementing cost-cutting initiatives to combat escalating healthcare costs, putting even greater pressure on pharma companies. In addition to the credit crunch, ever fewer novel products are coming to market, contributing to the declining return on investment.

Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

Innovative Clinical Trial Design and Management is a report published by Business Insights that explores the major types of adaptive design and their role in dose-finding. The report investigates seamless Phase 2/3 trials and adaptive trials in pharmacogenomics, assesses the logistical implications of adaptive trial implementations and reviews the current regulatory standpoints of the FDA and EMEA.

The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends

Emerging Role of Postmarketing Clinical Research is a report published by Business Insights that uses detailed case studies and market scenarios to examine the latest issues surrounding phase IV trial applications. The potential to leverage competitive advantage with postmarketing research is assessed by measuring the implications for formulary access, product marketing, indication expansion and reimbursement coverage.